Xiao-yu Liang
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Medial retropharyngeal nodal region sparing radiotherapy in nasopharyngeal carcinoma: five year analysis of open label, non-inferiority, multicentre, randomised phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: March 31, 2026
LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9+ macrophages and enhances radiation-induced antitumor immunity.
Journal: The Journal of clinical investigation
Published: May 05, 2025
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.
Journal: Cancer cell
Published: August 17, 2023
Oral chemotherapy versus observation alone in nasopharyngeal carcinoma patients with persistently detected circulating cell-free Epstein-Barr virus DNA during follow-up.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 11, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: February 06, 2023
TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma.
Journal: Science advances
Published: January 06, 2023
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment.
Journal: Nature medicine
Published: September 28, 2022
Low-dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma.
Journal: Cancer communications (London, England)
Published: May 16, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026